New diabetes clinical trial: Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.
- Get link
- X
- Other Apps
Published on: October 26, 2020 at 09:30PM
Condition: Dyslipidemia Associated With Type II Diabetes Mellitus
Interventions: Drug: BERLIM 25/10 association; Drug: EMPAGLIFLOZIN; Drug: ROSUVASTATIN CALCIUM; Other: BERLIM 25/10 ASSOCIATION PLACEBO; Other: EMPAGLIFLOZIN PLACEBO; Other: ROSUVASTATIN CALCIUM PLACEBO
Sponsor: EMS
Not yet recruiting
https://ift.tt/2HqTcvh
Condition: Dyslipidemia Associated With Type II Diabetes Mellitus
Interventions: Drug: BERLIM 25/10 association; Drug: EMPAGLIFLOZIN; Drug: ROSUVASTATIN CALCIUM; Other: BERLIM 25/10 ASSOCIATION PLACEBO; Other: EMPAGLIFLOZIN PLACEBO; Other: ROSUVASTATIN CALCIUM PLACEBO
Sponsor: EMS
Not yet recruiting
https://ift.tt/2HqTcvh
Comments
Post a Comment